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The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2
has no publicly available vaccine or antiviral drugs at the time of writing.
An attractive coronavirus drug target is the main protease (Mpro, also
known as 3CLpro) because of its vital role in the viral cycle. A significant
body of work has been focused on finding inhibitors which bind and
block the active site of the main protease, but little has been done to address
potential non-competitive inhibition, targeting regions other than the active
site, partly because the fundamental biophysics of such allosteric control is
still poorly understood. In this work, we construct an elastic network
model (ENM) of the SARS-CoV-2 Mpro homodimer protein and analyse
its dynamics and thermodynamics. We found a rich and heterogeneous
dynamical structure, including allosterically correlated motions between
the homodimeric protease’s active sites. Exhaustive 1-point and 2-point
mutation scans of the ENM and their effect on fluctuation free energies
confirm previously experimentally identified bioactive residues, but also
suggest several new candidate regions that are distant from the active site,
yet control the protease function. Our results suggest new dynamically
driven control regions as possible candidates for non-competitive inhibiting
binding sites in the protease, which may assist the development of current
fragment-based binding screens. The results also provide new insights into
the active biophysical research field of protein fluctuation allostery and its
underpinning dynamical structure.
1. Introduction
Over 2020, a rapidly spreading disease named COVID-19 caused by the novel
coronavirus SARS-CoV-2 has generated a global pandemic. Preventivemeasures
have been taken by a majority of countries, but no vaccine or anti-viral drugs
exist, at the time of writing, although candidates are under trial. In the longer
term therefore, the identification of all potential inhibitor sites at all points of
the viral life cycle is of interest. Here we focus on the low-frequency dynamical
structure of the virus’ main protease, an important molecular machine in the
viral cycle, and identify critical residues in its allosteric control. Thework is infor-
mative for inhibitor design by identifying control regions of the protein that are
distant from, rather than proximal to, its active sites. Allosteric mechanisms for
distant control of binding and activation fall into two main classes: those
which invoke significant conformational change (the original scenario of
Monod et al. [1]), andmechanisms that invoke themodification of thermal (entro-
pic) fluctuations about a fixed, mean conformation [2–5]. Such ‘fluctuation
allostery’ recruits mostly global, low-frequency modes of internal protein
motion, which are well captured by correspondingly coarse-grained mechanical
representations of the protein [6,7]. One effective tool at this level is the elastic
network model (ENM) [8]. The ENM resolves protein structure at the level of
alpha-carbon sites only, which are represented as nodes connected by harmonic
© 2021 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
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springs within a fixed cut-off radius from each other. Local
point mutation can be modelled by changing the moduli of
springs attached to the corresponding residue, and effector
binding by the addition of nodes (and local harmonic poten-
tials) at the corresponding coordinates. The most significant
contributions to both the correlated dynamics of distant resi-
dues, and to the entropy arising from structural fluctuation,
come from global modes, whose ENM approximation allows
straightforward calculation. This approach was successfully
used to identify candidate control residues whose mutation
may control allostery of effector binding in the homodimer
transcription factor CAP [9].
This study, and others, have shown that, while the huge
reduction in the number of degrees of freedom that the ENM
constitutes does not capture the quantitative values of free
energies, or the numerical changes to those values onmutation
that are seen in experiment, it can rank them qualitatively, and
also identify the functional form of the thermal dynamics of a
protein for a significant set of low-frequency modes. Naturally,
those aspects of protein function that rely on side-chain
structures and interactions, or on very fast processes, are not
captured by any coarse-grained model, including those of the
ENM class. However, low-frequency dynamics and processes
that modify them can be addressed by ENMs. In particular,
the coarse-graining of the ENM can determine which residues
present as candidates for allosteric control through mutation.
The method, and the open software (DDPT) used in the pre-
vious study on allosteric homodimers, and confirmed by
experimental calorimetry on model-designed mutations [10],
is deployed here in a similar way (see Material and methods
section) to a coarse-grained ENMof the SARS-CoV-2main pro-
tease. The motivation for a numerical analysis of possible
dynamically controlled allostery in this protein arises from
recent experimental studies on the structurally similar SARS-
3C-like protease that have already identified two regions
where mutations inhibit the protein function without signifi-
cant structural change [11,12]. This evidence that long-range
dynamical effects are both implicated in, and offer control of,
allosteric function in this family of proteins suggests a dynamic
structure of sufficient richness to warrant a full analysis.
In the following, we present structural and functional
detail of the SARS-CoV-2 Mpro as further essential back-
ground, then describe our simulations and their results,
before concluding with a discussion of the potential to exploit
its dynamical allostery for non-competitive inhibition.
1.1. The SARS-CoV-2 main protease protein
At the time of this study (14 December 2020) more than 71 000
papers have been published in relation to the virus (see
COVID-19 Primer). However, work is still in progress to
identify biological and molecular pathways the virus takes.
Fortunately, significant research has already been directed to
the very similar coronavirus—SARS-CoV, first identified
in 2003. The SARS-CoV and SARS-CoV-2 genetic sequences
are approximately 80% identical [13]. Both viruses encode
a main protease (Mpro), also known as the 3C-like protease
(3CL pro). In its active formMpro is a two-protomer homodimer
with one active site per homodimer chain [14]. A recent crystal
structure for the SARS-CoV-2 Mpro is shown in figure 1, along-
side the co-crystallized N3 inhibitor, which occupies the active
sites of the protease dimer, between domains II and III of
each domain. Away from the dimer interface, the protein
structure is dominated by beta-sheets, while the interface
itself is composed of adjacent helices and loops. Although
Mpro is a relatively compact protein (fewer than 310 residues
per chain), it plays a vital role in the viral cycle of both corona-
viruses: it divides polyproteins expressed from the viralmRNA
into its functional non-structural units [15]. This functional role
makes SARS-CoV-2 Mpro an appealing target for drug design.
The major research effort to date has been focused on the
competitive inhibition of SARS-CoV-2Mpro, i.e. by directly tar-
geting the active site with molecules that competitively bind to
the active site ‘pockets’ [13,16–18].
A significant body of work has been recently published
investigating inhibitors for the SARS-CoV-2 main protease
via virtual screening and molecular dynamics simulations
[19–26]. In 2011, itwas found thatN214Amutationdynamically
inactivates SARS-CoVMpro [11]. The same research group later
characterized another SARS-CoV Mpro mutation, S284-T285-
chain A chain B
N3
Figure 1. The crystal structure of the SARS-CoV-2 Mpro with N3 inhibitor. Chain A of the dimer is shown in blue, while chain B, in orange. Domains are labelled with
boxed Roman numerals (I, II and III). Amino acid residues of the catalytic dyad are indicated as yellow spheres for H41 and magenta spheres for C145. Asterisks mark
residues from chain B (orange). Chain termini are shown as spheres and labelled N and C for chain A (blue) and N* and C* for chain B (orange). The N3 inhibitor is
shown as green sticks. Experimentally identified dynamically allosteric residues N214 and SAL284-286 are shown as labelled black spheres. Identified control residue
candidates for dynamic allostery in the SARS-CoV-2 Mpro that are distant from the catalytically active residues H41 and C145 are coloured in black on both homo-








I286/A, which dynamically enhances the protease catalytic
activity more than threefold [12]. In SARS-CoV-2 Mpro, two of
those amino acids (T285 and I286) are changed to T285A and
I286L with respect to SARS-CoV Mpro. However, only a little
enhancement in catalytic activity is observed [13]. This delicate
potential control region will appear below in our analysis (see
§2.2.2). Due to the high sequence conservation between the
two coronaviruses, and 96% amino acid sequence identity
between the main proteases, SARS-CoV-2 Mpro might possess
similar allosteric features. Furthermore, in another study,
researchers found the root mean square deviation (RMSD) of
0.53Å for apo (ligand-free) forms of two corona viruses’ main
proteases (PDB accession 2bx4 and 6y2e) [13]. These findings
together evidence that the N214A mutation operates through
a fluctuation allostery mechanism and structural similarities
between two proteases motivate the analysis of the coarse-
grained dynamic structure of SARS-CoV-2 Mpro reported
here. In the following, we apply the ENM techniques of [9] to
this purpose, looking in particular to identify non-active,
yet allosteric, sites for non-competitive inhibition.
2. Simulations, results and discussions
No crystallographic structure of the SARS-CoV-2 Mpro1 active
form with a polyprotein is available to date, but only empty
(apo) structures or structureswith synthetic ligands/substrates
attached to the active site. Therefore, the ENM study reported
here used a recent crystallographic structure (PDB accession
6lu7 [16]) with competitively inhibited active site to calculate
fluctuation free energies and consequent allosteric energies
and their modification under mutation. The inhibited (with
N3 inhibitor) and ligand-free structures of the protein are
almost identical, shown in electronic supplementary material,
figure S1. Resolutions for the structures shown are 2.16 Å
and 1.75 Å, respectively, while RMSD between them is
under 1.5 Å for C
α
atoms. Evidently, very little structural
change occurs upon inhibitor binding. These findings
further support the hypothesis of dynamically driven allosteric
control of SARS-CoV-2 Mpro, and provide a structure (6lu7)
on which to base an ENM construction (electronic supple-
mentary material, Sec. A). All three PDB files used in this
study were derived from original crystallographic structure
of SARS-CoV-2 Mpro with N3 inhibitor.
The resulting ENM of Mpro is shown in figure 2. It takes C
α
node masses as the whole residue mass, and uses a cut-off
distance for harmonic connecting springs of 8 Å, based on opti-
mizing the comparison of mode structures between ENM and
full molecular dynamics simulations, in previous work on
catabolite activator protein [9,27] (electronic supplementary
material, Sec. B). In the case of N3 inhibitor, short polypeptide
AVL was coarse-grained in the same way as the main
chain amino acids while the other heavy atoms (C, N and O)
have been treated as individual nodes with atomic masses
(electronic supplementary material, figure S2).
Balancing the requirements of: (i) sufficient spatial resolution
of dynamics; (ii) requirements not to include unphysically
small-scale structure; (iii) acceptable convergence of thermodyn-
amic calculations; and (vi) compatibility with the previous
studies [28] leads to the choice of summing the first real 25
modes in SARS-CoV-2 Mpro ENM calculations (electronic sup-
plementary material, Sec. C). Although high-wavenumber
modes may contain apparent contributions to allosteric effects,
it is essential, when deploying ENM coarse-graining, to avoid
including dynamic structures with length-scales comparable
to the residue–residue spacing, where structural detail is no
longer faithfully captured (for stability and convergence proper-








Figure 2. Constructing ENM of SARS-CoV-2 Mpro step-by-step. (a) SARS-CoV-2 Mpro secondary structure cartoon. (b) Elastic model of Mpro generated with PyANM
package in PyMOL. C
α
atoms are shown in blue; while node-connecting springs (black) are shown only for one chain for comparison. (c) The first real vibrational








electronic supplementary material, section C, where the
physically relevant low-frequency structure is differentiated
from nonphysical contributions from high modes). We note
that similar studies by others have employed as few as the
first real 10 modes [29].
2.1. Residue–residue dynamic cross-correlation map
The first quantity of interest is the map of dynamic corre-
lations, which indicates for each residue on the protein
those other residues whose motion correlates with its own
(equation (4.1)). This gives a detailed summary map of the
homodimer dynamical structure, and is also significant ther-
modynamically, since the same elastic communication drives
both correlations and allosteric control [4]. The dynamic
cross-correlation maps for all residues in the ENM apo
(ligand-free), holo1 (only one active site at chain A occupied)
and holo2 (both active sites occupied) structures are shown in
figure 3. We discuss the dynamic features of each structure in
the following.
2.1.1. Apo
The N-terminus of each chain positively correlates with resi-
dues adjacent to the active site (res 100–200) on the other
chain, reaching cross-correlation values up to 0.81. This is
due to physical proximity rather than allostery (figure 3a,
apo, wide purple rectangles in lower-right and upper-left
quadrants). Significantly however, the dynamics of the
regions around active sites on both chains positively corre-
late, in this case allosterically, with each other (figure 3a,
apo, green square and rectangle in lower right quadrant).
However, cross-correlation between the catalytic dyad resi-
dues on opposite chains is almost non-existent: 0.08 and
0.00 for H41 and C145, respectively, although H41–C145 cor-
relation reaches a value of −0.18. The active site regions are
spatially distant: they do not appear at the corresponding
location on a proximity map (figure 3a, apo, green square
and rectangle in upper left quadrant). The T201–N214
alpha helix (which contains the experimentally sensitive
N214) on one chain dynamically anti-correlates with H41
on the opposite chain with values ranging from −0.11 to
−0.40. The same helix, from residue 201 to 213, also anti-
correlates with C145 on the opposite chain (from −0.10 to
−0.32); while surprisingly (since its mutation is effective in
allosteric control) N214 shows no correlation (−0.02) with
the catalytically vital C145 at all. We observe strong posi-
tive correlation, however, between this helix and two
regions forming the active site pocket: residues K137–N142
(loop) and E166–H172 (β-turn) with values reaching 0.50
(figure 3a, apo, narrow purple rectangles in lower right and
upper left quadrants), although this correlation can partially
be accounted for by spatial proximity. S284-L285-A286 resi-
dues (henceforth SLA) on one monomer show positive
cross-chain dynamic coupling of motion with the identical
residues on the other with cross-correlation value no lower
than 0.42, in this case through spatial proximity (figure 3a,
apo, orange squares in lower-right and upper-left quadrants),
but a somewhat smaller positive correlation spans residues
275–306 (N terminus) on both chains with respect to SLA.
This effect suggests strong SLA coupling to a large fraction
of the protein domain not containing the active site. Further-
more, SLA positively correlates with the T201–N214 alpha
helix (with maximum value of 0.20), which contains the
experimentally determined dynamically allosteric residue
N214 (0.14, 0.01 and 0.16 for each residue in the SLA, respect-
ively). Finally, SLA negatively correlate with the active site’s
catalytic dyad (−0.23 and −0.25 on average for H41 and
C145, respectively) and residues around it (figure 3a, apo,
not shown). Thus, we observe both dynamic correlation at
a distance, as well as that due to immediate spatial proximity,
supporting previous findings regarding SARS-CoV Mpro
dynamically allosteric inactivation.
2.1.2. Holo1
The positively correlated dynamics between the active sites
are strongly enhanced by addition of the first ligand, especially
in regard to the two beta sheets (G146-I152 and V157-L167)
and a beta turn between them, with most residue–residue
cross-correlation values over 0.1 with 0.29 maximum
(figure 3a, holo1, green square in the lower right quadrant).
Also, we can clearly see an enhancement of negative cross-cor-
relation in the real space representation around the active site
on chain B (figure 3b, dashed squares in apo and holo1; elec-
tronic supplementary material, figure S3). Interestingly, and
by contrast, the region displaying positive correlation around
residues 50–70 with respect to residues around the active site
in the apo form is decreased in the holo1 structure (figure 3a,
holo1, green rectangle in the lower right quadrant). In the
holo1 form, the structural symmetry of the apo form is
broken, permitting an asymmetric correlation between chains
A and B (figure 3, holo1, across the diagonal of the lower
right quadrant). The biologically active residues (green ticks)
show up in the ligand’s correlation with (host) chain
A. However, four other regions, not cited in the literature to
date, also show strong dynamic correlation with the ligand.
Two of them (res 17–32 and 120–131) can be vividly observed
as spatially proximal to the ligand from the corresponding dis-
tance map. Two other regions exhibiting positive cross-
correlation are, however, distant from the ligand (figure 3a,
holo1, blue rectangles in lower right and upper left quadrants).
These regions span residues 67–75 and 77–91, respectively, and
include two beta sheets and a beta turn in each case with most
of the values over 0.1 and a maximum value over 0.6. The pre-
viously reported dynamically allosteric residue 214 (chain B)
correlates with the ligand on chain A (values ranging from
−0.11 to 0.12); potentially due to spatial proximity. The closest
ligand residue to N214 is 11.2 Å away. Moreover, the ligand
shows positive correlation at distance with the beta sheets on
the opposite chain (figure 3a, holo1, blue rectangles in upper
right quadrant). The fact that the ligand’s motion positively
correlates with beta sheets at residues 67–75 and 77–91 on
both chains suggests strong chain–ligand coupling to residues
67–91 on both homodimer chains. SLA and the residues
around it dynamically couple to the same residues on the
opposite chain (figure 3a, holo1, orange square in lower right
quadrant). The structural C2 symmetry-breaking upon ligand
binding decouples motion of residues which are distant from
the active site (figure 3a, holo1, orange square in lower right
quadrant). Thus these residues can engage in collective
motion driven by spatial proximity to their neighbours. Not
seen on apo cross-correlation map, the second half of the
N261-N274 alpha helix on chain B appears to correlate posi-
tively with four distant residue groups in 15–100 region on
chain A (figure 3a, holo1, orange rectangle in upper left and








produced an interesting ‘H’ shape correlation (on the cross-
correlation map) between four beta sheets, two on each
chain: G146-I152 and V157-L167 on chain A, G109-Y118
and S121-R131 on chain B with values from −0.23 to 0.57
(figure 3a, holo1, purple square in lower right quadrant). This
group motion across chains is partially caused by two
(a) (b)chain A chain B
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Figure 3. The cross correlation of the motion of 6lu7 ENM. (a) The cross-correlation maps calculated for the first real 25 modes (bottom-right region of the plots)
and spacing between residues (C
α
nodes) and ligand nodes (top-left region of the plots) for apo, holo1 and holo2 forms. The first colour scale shows the extent of
cross correlation, with a cross correlation of 1 (red) indicating perfectly correlated motion, −1 (blue) showing perfectly anti-correlated motion and 0 (white) no
correlation. The second colour scale (black to white) depicts the Euclidean distance between two ENM nodes in the Cartesian space in 0–16 Å range. The secondary
structure of Mpro is indicated along the horizontal residue axes, with cyan waves indicating alpha helices, and magenta triangles indicating beta sheets. Coloured
lines on the vertical axes point to the boxed regions on the plots mentioned in the main text. The green ticks on the axis indicate the location of the biologically
active residues (table 1). (b) A real-space representation of the correlations in 6lu7 ENM with respect to residue 145 on chain A (green sphere). The dashed squares
indicate the anti-correlation enhanced in apo–holo1 and reduced in holo1–holo2 transitions. The cross correlation matrix was calculated using only the C
α
atoms for








neighbouring beta turns sticking out of active site protein
domains (figure 3a, holo1, purple square in upper left
quadrant).
2.1.3. Holo2
When a second ligand is added, the strong correlation between
the active sites present in holo1 is diminished (figure 3a, holo2,
green square in lower right quadrant; figure 3b, dashed squares
in holo1 and holo2), while previously lowered correlations
elsewhere re-attain values in the apo form level (green rec-
tangle in the same quadrant and figure). The region around
SLA and the N261–N274 alpha helix, which shows strong
dynamical coupling with the residue groups in interval 15–
100 of the holo1 form, is reduced on binding the second effector
to its previous apo level correlation (figure 3a, holo2, orange
square and rectangle in lower right quadrant). Such loss (or
equivalently, and in other cases, gain) of previous fluctuation
correlations between distant sites, on binding at a third site,
is the basis of mutation control of dynamical allostery [9].
The principal mechanism is the perturbation of the global
eigenmode structure of the protein. A reduced correlation
arises from a reduction, on binding, in the number of modes
for which the two correlated sites are both near anti-
nodes. This was recently identified in detail as a route to nega-
tive allostery [30]. The newly added ligand on chain B shows
the same correlation-at-distance with the L66-A70 and
V73-L75 beta sheets, excluding the beta turn in between them
(figure 3a, holo1, blue rectangles in upper right quadrant).
Nevertheless, the cross chain coupling between active site
and the alpha helix (T201–N214) is further increased. The cor-
relation is split into three distinctive regions in locally ‘wedge-
like’ shapes on the map, two of which are around active site.
These structures were also seen in the CAP cross-correlation
map [9], and indicate the two contributing beta strands
acting as a local hinge region. The third region is located
around a beta sheet at S121-R131, which is not bound to the
ligand (figure 3a, holo2, purple squares in lower right and
upper left quadrants). The cross-correlation displays an inter-
esting structure along the helix from residue N201 to T214:
the third region is split into three zones: positive, negative
and positive correlation. This sign change is reminiscent of
the third harmonic of a standing wave with two nodal points
(in three dimensions those are nodal planes). The negative
correlation region is absorbed by the two positive regions as
we reach residue N214. Unsurprisingly, the two ligands exhibit
identical correlations with their host and opposite chains.
Noteworthy, each ligand has dynamics correlating positively
with the termini of the opposite chain, arising principally
from the spatial proximity of C and N termini to the opposite
chain’s active site.
2.2. Mutation scans for thermodynamic control
The ENM calculations were extended to calculations of
fluctuation-driven free energies (equation (4.2)) of variousmod-
elled wild-type and mutated state of SARS-CoV-2 Mpro. ‘Point
mutations’ are modelled in these ENM calculations, as in [9]
by softening or stiffening all the harmonic springs attached to
each residue in a complete scan of equally spaced spring
moduli with ratios to their wild-type value in the range from
0.25 to 4.00. Previouswork (by comparison to atomisticmolecu-
lar dynamics and experimental calorimetry on mutations) has
shown that this range is appropriately calibrated to the effects
of mutations of a single step in side-change hydrophobicity
[9]. Figure 4a reports the free energy changes (Gmut−Gwt)/
|Gwt| induced in the entire homodimer when this scan of
point mutations is made. Figure 4c reports the effect of the
same mutational scan on the allosteric free energy K2/K1
(equation (4.3)) of binding between the two active sites.
2.2.1. Free energy mutation scan on apo structure
All experimentally identified active sites (besides res 163–167)
appear on the mutation scan of the 6lu7 apo structure, a
somewhat remarkable result considering that no ligand is
present to emphasize the special nature of the active sites.
They appear dynamically predisposed to dynamic allosteric
communication, in agreement with the cross-correlation
map (figure 3). Both termini display mutation peaks due to
their spatial proximity to the active sites. Additionally, a
very sharp peak is seen around residues 187–192 where a
free loop forming the active site is located. The seven new
regions seen on the cross-correlation map (res 17–32, 67–75,
77–91, 97–98, 120–131, 201–214 and 261–274) form distinctive
peaks on the mutation scan as well.
Furthermore, the experimentally identified residue N214 is
signposted by these calculations: its computational mutation
generates the largest fluctuation free energy change upon
spring stiffening of 0.29% at kR/k = 4.00. The largest negative
free energy change value of 0:47% is produced upon spring
relaxation of M276 at kR/k = 0.25 (these two points define the
amplitude of the colour bar of the figure). Although the cataly-
tically paramount residue C145 is not as sharp as other peaks, it
appears with greater strength in a higher mode summation
(electronic supplementary material, figure S6A). The map is
mostly qualitatively anti-symmetric around its mid-line (indi-
cating the wild-type). However, the quantitative behaviour of
three regions is worthy of attention: the region around residue
50, before 100, at residue 150, as well as the sharpest region
around residues 187–192. Relaxation of stiffness at those
points causes larger energy change than does stiffening. A
very narrow region, not identified on the cross-correlation
map, at residues 97–98, preceding a small beta sheet at res
Y101–V104, appears sharply when local interaction strengths
are relaxed. A new broad region of strong sensitivity to
mutation appears on this map at residues 261–293, which
includes an alpha helix at V261-N274. This helix is located on
the surface of the protein far from the active site. This region
also contains SLA which appear as sharp lines in figure 4a;
and is especially responsive to spring constant change at
L285: a free-energy change of 0.19% at kR/k = 4.00 and
0:29% at kR/k = 0.25. L285 is in the middle residue of the
triad affecting two of its neighbours. Furthermore, L285 on
one chain is in the closest contact with its counterpart on the
other chain (5.3Å).
We also note seven residues which are located on the
homodimer chains’ interface (K5, P9, K12, E14, M276, I281
and S284), recalling that in the CAP homodimer, residues
located on the interface were critical in allosteric regulation
[9]. Especially responsive is E14 located on the very first
alpha helix.
2.2.2. Allosteric free energy mutation scan
The first result from the ENM calculation of the allosteric free
energy for binding-site occupation is that K2/K1 = 1.032≈ 1








modes) is non-cooperative. Nevertheless, we can identify
regions that are sensitive to even slight change in local stiffness
which again are around biologically active areas. All pre-
viously marked active regions show up to some extent;
especially vivid is the region around catalytic residue H41
and, as already appeared in the apo mutation scan, the loop
around the active site (res 187–192). Residue N214 shows
veryweak allosteric control in this scan. The local environment
around N214 is mainly hydrophobic (electronic supplemen-
tary material, figure S7). Therefore, the experimentally
reported N214Amutation corresponds to a local structural stif-
fening (asparagine (N) is hydrophilic while alanine (A) is
hydrophobic). This is indeed the region of parameter space
(kR/k > 1) where this mutation displays a weak effect in the
ENM, but a strong response upon relaxation. In SARS-CoV-2
Mpro residues T285 and I286 are replaced by L285 and A286
with respect to SARS-CoV Mpro. Purely from the perspective
of hydrophobicity of residue and environment, the former
mutation would correspond to kR/k > 1, while the latter
emulates kR/k< 1. However, no exact comparison
with experimental data can be made as there are no data
on how SLA simultaneous mutation affects SARS-CoV-2 Mpro
catalytic activity. Without data on single mutations within the
SLA region, we have no direct experimental verification of the
single S284A mutation (which in our ENM corresponds to kR/
k> 1 for similar reasons as for N214A mutation). We see a
decrease in cooperativity for S284 spring stiffening, while for
spring relaxation the ENM’s cooperativity increases.
2.3. Two-point mutational scans
It is of interest to explore the cooperative effect of two-point
mutations in models of fluctuation allostery, as previous work
has indicated that double mutations may combine nonlinearly
in control of the allosteric landscape of proteins [27]. This
numerical scan explores cases where mutations are made on
both or only on one of the single homodimeric chains: exper-
imentally this is a possible, but not a trivial, task. However it
can reveal contribution of each chain alone to fluctuation and






















































Figure 4. Mutation scan maps for thermodynamic control of Mpro calculated from the ENM over the first real 25 fluctuation modes. (a) A map for the fluctuation
free energy change. The map plots the relative change in free energy to the wild-type ((Gmut− Gwt)/|Gwt|) due to the dimensionless change in the spring constant
(kR/k) for the mutated residue with the amino acid number shown. White corresponds to values of free energy predicted by the wild-type ENM. Red corresponds to
an increase in (Gmut− Gwt)/|Gwt| (decreased value of Gmut comparing to Gwt), whereas blue corresponds to a decrease in (Gmut− Gwt)/|Gwt| (increased value of Gmut
comparing to Gwt). (b) The map for the vibrational free energy change plotted in real space onto the wild-type M
pro homodimer structure at kR/k = 4.00. (c) A map
for the global control space of allostery in Mpro. The map plots the change in cooperativity coefficient (K2/K1) due to the dimensionless change in the spring constant
(kR/k) for the mutated residue with the amino acid number shown. White corresponds to values of K2/K1 predicted by the wild-type ENM. Red corresponds to an
increase in K2/K1 (stronger negative cooperativity), whereas blue corresponds to a decrease in K2/K1 (weaker negative cooperativity or positive cooperativity). (d ) The








this section refers to results presented in the 2-point scans of
6lu7 ENM in figure 5. In order to present the response to all
double-mutations on a single two-dimensional plot, the
change in spring stiffness is not scanned; rather, just two con-
stant spring changes of 0.25 and 4.00 are considered in a
complete scan of residue pairs. Spring-stiffening 2-point muta-
tional scans (figure 5a,c), kR/k = 4.00, model the effect of small
molecule/ligand binding to the mutated residues (and would
also model mutations such as N214A); while kR/k = 0.25 map
looks at the opposite extreme to the stiffening case, which
would model mutations that weaken local bonding (figure 5b,
d). To explore possible nonlinearities in the combination of
different mutation strengths, scans in the complementary par-
ameter space of the two spring-constant changes were made
for selected pairs of mutations (C145 and H41, already ident-
ified as important control sites). The corresponding two-
dimensional plots of free energy and allosteric response are
given in electronic supplementary material, figure S8.
2.3.1. Free energy 2-point mutation scan on apo structure
The first measure, as in the single-point scans, is the difference
in total free energy of the apo structure. As on the 1-point map
for apo 6lu7 structure strong lines are observed (figure 5a,b),
but spring relaxation resolves fewer biologically active residues
than spring stiffening. In figure 5a only residues around H41, a
loop region forming active site at D187-A191 and N214 show
strong responses. On the other hand, stiffening (figure 5b)
resolves all bioactive residues except H163-L167 (beta sheet
forming the active site pocket) with an additional region
around a small beta sheet (Y101-V104), alpha helices (T201-
N214 and V261-N274) and loop region adjacent to the
latter helix. As in the case of the 1-point map (figure 4a)
M276 (−0.47%) and N214 (0.29%) define maximum absolute
response upon relaxation and stiffening of these residues on
both chains, respectively (figure 5a,b). In both cases, the SLA
region shows moderate fluctuation free energy change. We
conclude that stiffening is a better choice for resolving critical
residues in fluctuation free energy control. Note that, in the
case of this protein, the 2-point mutations combine approxi-
mately linearly: the effect of the first mutation (vertical lines)
is not strongly affected by the second mutation. Nevertheless,
responses to relaxation and stiffening give qualitatively
different plots. The weak nonlinearities that are present are
more evident when mutations on non-identical sites are
combined (see electronic supplementary material, figure S8).
2.3.2. Allosteric free energy 2-point mutation scan
Finally, the effect of all double mutations upon spring relax-
ation and stiffening on the allosteric free energy between
the two active sites was calculated (figure 5c,d). While the
2-point apo maps show qualitatively different behaviour for
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Figure 5. Two-point mutational maps for 6lu7 ENM with all possible pairwise combinations of residue mutations with equal spring constant change kR/k equal to
0.25 and 4.00 over the first real 25 fluctuation modes. (a,b) 2-point mutational maps for 6lu7 ENM with all possible pairwise combinations of residue mutations with
equal spring constant change (a) kR/k = 4.00 (spring stiffening) and (b) kR/k = 0.25 (spring relaxation). (c,d ) Maps for the two-dimensional global control space of
allostery in Mpro for (c) kR/k=4.00 and (d ) kR/k = 0.25 with colour bar centre at K2/K1 = 1.032. Black solid lines separate two homodimer chains, while dashed lines








mutation maps are qualitatively identical, modulo an inverted
allosteric free energy change sign. A new strong control site
that did not appear on the 2-point apo maps (figure 5a,b) is
found at the beginning of the second beta-sheet (T25-L32) on
each chain (figure 5c,d). Additionally, S1 and G302 exhibit
strong allosteric control due to spatial proximity to the active
site and, thus, the ligand. The apparent increased cooperativity
for both mutations (in most cases) on chain A, and the same
pattern of decreased cooperativity on chain B, is due to the
formal symmetry breaking through choice of the first binding
site at chain A. Mutation of residues around H41 constitutes
an exception, and has an opposite effect on allostery to all
others. The dashed lines in figure 5 represent the 1-point allo
scan in figure 4 for corresponding kR/k values. In that scan
K2/K1 values range from 1.003 to 1.068, while for these
2-point mutational scans the range is significantly increased:
0.719–1.540 for kR/k = 0.25 and 0.842–1.259 for kR/k = 4.00.
This calculation draws attention to an additional advantage
of the 2-point scans: while N214 did not exhibit allosteric control
on the 1-point map (figure 4c) over 25 fluctuation modes, it
appears as a strong line in all quadrants on the 2-point maps.
However, when the lines intersect in the cross-chain quadrant
K2/K1 reaches almost wild-type value (corresponding to
making exactly the same change on both monomers). This
effect explains why we do not observe allosteric control of N214
on the 1-point mutational map: evidently, when the bold lines
intersect (identicalmutation or binding onbothdomains) alloste-
ric effects interfere destructively. Thus, in the 1-point allo scan for
6lu7 ENM amplitude of K2/K1 is lower than in the 2-point muta-
tional allosteric scan or hardly applies. The SLA region appears
neither on the 1-point nor 2-point global maps for dynamic
regulation of allostery in spite of its presence on the free-energy
apo scans. This absence of control indicates the limited coupling
between SLA and the given ligand (N3 inhibitor).
3. Discussion: what does ENM tell us about
SARS-CoV-2 main protease?
The ENM analysis reinforces previous findings in application
to other proteins, that in the SARS-CoV-2 Mpro as well, local
harmonic potentials within the equilibrium protein structure,
but without mean structural change, can identify already bio-
logically active sites known from experiment. Furthermore,
there is no need to possess holo forms of the protein to locate
those active sites, whose correlated dynamics are already
clear in the apo form. Calculations of those sites where total
free energies are sensitive to mutations converge well with
the limit of the sum over normal modes. The convergence of
calculations of control of the allosteric free energy itself is
more subject to noise, being a higher-order difference-quantity,
but sufficient to identify strong candidates for control regions
(electronic supplementary material, figure S6).
The analysis shows that SARS-CoV-2 Mpro possesses a rich
dynamical structure that supports several long-distance allo-
steric effects through thermal excitation of global normal
modes. In particular, the motions in the vicinity of two active
sites are correlated within the first 25 non-trivial normal
modes, especially in the singly bound dimer. Although, at
the level of ENM calculations, this does not lead to cooperativ-
ity in the wild-type structure, it does render the protein
susceptible to the introduction of cooperativity by mutation.
Our methodology is further supported by the ENM
dynamics sensitivity to residue 214 and 284–286 mutations
which have been shown by experiment to dynamically con-
trol SARS-CoV Mpro.
The ENM calculations have identified new sites whose
local thermal dynamics dynamically correlate with those of
the active sites, and which also appear on global maps for allo-
steric control by single or doublemutations. The new candidate
control regions are summarized in table 1. In particular, resi-
dues around the beta sheets (Y101-V104, G109-Y118 and
S121-R131) and the alpha helices (T201-N214 and V261-
N274) are novel, and distant from the active site (figure 1).
The positions of these residues suggest them as possible candi-
dates for non-competitive inhibiting binding sites. We also
draw attention to eight residues located on Mpro interface sur-
face (table 1) as a further set of potential dynamically allosteric
control residues.
Computational studies such as this, therefore, accompany
and support concurrent experimental programmes of scanning
for small-molecule binding candidates to the protein. We note
that several candidatemolecules, identified in very recent large
crystallographic fragment screens against SARS-CoV-2 Mpro
[31,32], bind to regions suggested as dynamically sensitive con-
trol candidates in this study. Such experimental programmes
are essential in identifying inhibitors that are both effective,
and have sufficient total binding free energies to the protein.
Coarse-grained simulations such as the ENM method we
have employed, while powerful in locating candidates for sus-
ceptible binding sites, cannot deliver predicted values for total
free energies of binding. Fully atomistic computations are
potential alternatives to experiment, as a recent study has
shown for a (competitive) inhibitor for SARS-CoV-2Mpro, Leu-
coefdin (−41.71 kcal mol−1) [33], and nine other candidate
ligands (with binding energies up to −82 kcalmol−1) [34].
However, to date there have been no calculations nor exper-
iments on the binding energies of non-competitive yet
inhibiting ligands. Because ENM calculations identify entropic
contributions to free energy arising from fluctuations around a
mean conformation, they typically deliver a sizeable fraction of
the thermal energy kBT per mode affected. This sets the typical
scale at a few kilojoules per mole for the free-energy changes
predicted by the model, represented in the results presented
here. Previous work has found that experimental free energies
are typically ordered in the same sequence as the ENM values,
Table 1. SARS-CoV-2 main protease key information used in this study: PDB ID; experimentally identified bioactive residues of SARS-CoV Mpro reported in the
literature; active regions which we identified in this study, distant from the active site for SARS-CoV-2 Mpro (electronic supplementary material, Sec. D).
protein PDB ID experimentally identified bioactive residues
computationally identified distant control
residues (this study)
SARS-CoV-2 6lu7 41, 49, 143-5, 163-7, 187-192 [20] 5, 9, 14, 109, 111, 127, 197-8, 200, 205, 214,








though larger by factors that may arise through coupling of the
global modes to unresolved local modes [4,9,35].
Furthermore, the ENM employed in this study was
specific for the given inhibitor. Other ligands might, of
course, show different behaviour in the corresponding holo
structures and display other ‘hot-spots’; however, the appear-
ance of active regions, and their coupling, in the apo structure
suggests that there are general properties that emerge from
the global elastic structure of the protein.
Aswell as providing specific information on the SARS-CoV-
2 Mpro structure of the calculations reported there, the findings
of this study also contribute to the large programme of research
on fluctuation-induced allostery without conformational
change. In particular, the general question of the focusing of
dynamic correlations between distant (so candidate allosteric)
sites is solved in a highly specific way by this structure. It also
constitutes a system for which double mutations contribute in
a predominantly linear, or weakly nonlinear, addition, in con-
trast to findings with other allosteric homodimers. This
pattern includes the phenomenon we identified in the case of
some single point mutations made identically and simul-
taneously in both monomers, whose cancellation in the
1-point mutational scans can mask their potential sensitivity
as target sites. Finally, the appearance of control regions on
the exterior surface of proteins, with obvious pharmacological
application, generates other general questions in the biophysics
of fluctuation elasticity in globular proteins.
4. Material and methods
Normal mode analysis (NMA) of ENM describes protein
motions around equilibrium and can be used to calculate the par-
tition function for large-scale harmonic thermal fluctuations in
protein structure, including those responsible for allostery [36].
Two main approximations of NMA are:
— The structure fluctuates about a local energy minimum. Con-
sequently, no other structures beyond the given equilibrium
can be explored.
— The force field everywhere arises from sums over ENM
harmonic.
The whole NMA method can be reduced to three steps:
1. Construct mass-weighted Hessian for a system. For a protein
ENM the system consists of the coordinates of the C-alpha
atoms (N) for each residue from the corresponding PDB
structure.
2. Diagonalize the mass-weighted Hessian to find eigenvectors
and eigenvalues of the normal modes.
3. Calculate the partition function (and so free energy) from the
product over the normal mode harmonic oscillations.
The diagonalization of the 3N × 3N mass-weighted Hessian
matrix is written as
A
1 ~HA ¼ L;







p : the potential energy function
V; distance between nodes r; node masses m. The eigenvectors
of the mass-weighted Hessian matrix, columns of A, are the
normal mode eigenvectors a:
A ¼
j j j






Λ is a 3N × 3N diagonal matrix with diagonal values equal to the
associated normal modes’ squared angular frequencies ω2. The
potential function used in this study is
Vij ¼
kij
2 (rij  r
(0)
ij )
2 r2ij  r2c




where rc is a cut-off radius, which for this work is set at 8 Å; while
r(0) is the equilibrium distance between nodes derived from PDB
crystallographic structure. For the wild-type protein, all spring
constants are equal: kij = k = 1 kcal Å
−2mol−1.
4.1. Cross-correlation of motion
The cross-correlation C is estimated between an ENM node pair
as a normalized dot product sum between their normal mode















C value of 1 implies perfectly correlated motion, −1 perfectly
anti-correlated motion and 0 implies totally non-correlated
motion.
4.2. Normal mode fluctuation free energy
Using statistical mechanics, it is possible to calculate an estimate to
the fluctuation free energy of a system using the frequency of
vibrations such as the normalmodes. For thismethod, the partition
function for the quantum harmonic oscillator [37], Z, for normal
mode k is given as
Zk ¼
exp ( (1=2)(h vk=kBT))
1 exp ( h vk=kBT)
,
where kB is Boltzmann’s constant, h is the reduced Planck’s con-
stant, T is temperature in kelvin and ω is, already mentioned,
angular frequency. Gibbs free energy (for a givenmode) expressed
in terms of partition function, with an approximation of little
change in volume, can be written as
Gk ¼ kBT ln
1





4.3. Ligand dissociation constant
When free energy change ΔG (electronic supplementary material,
Sec. C) is known for a dissociation reaction, corresponding dis-
sociation constant K can be estimated via
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